Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
54
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target

Liang Xia1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected];2 Department of Oral and Cranio-maxillofacial Surgery, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Yang Wang1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Yuhua Hu1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Chunye Zhang1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Ting Gu1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Lizhen Wang1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Jiang Li1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]
,
Wenwen Yu2 Department of Oral and Cranio-maxillofacial Surgery, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]Correspondence[email protected]
&
Zhen Tian1 Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China, [email protected]Correspondence[email protected]
 show all
Pages 6571-6579 | Published online: 30 Nov 2018

References

  • HashimotoKYamamotoHShiratsuchiHHER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization studyHistopathology2012606BE131E14222486195
  • ThompsonLWorld Health Organization classification of tumours: pathology and genetics of head and neck tumoursEar Nose Throat J20068527416579185
  • TianZLiLWangLHuYLiJSalivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese populationInt J Oral Maxillofac Surg201039323524219951834
  • MarxAHTharunLMuthJHER-2 amplification is highly homogenous in gastric cancerHum Pathol200940676977719269014
  • GlissonBColevasADHaddadRHER2 expression in salivary gland carcinomas: dependence on histological subtypeClin Cancer Res200410394494614871971
  • XiaLHuYLiJA low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 casesJ Oral Pathol Med201746316717427423271
  • YanMParkerBASchwabRKurzrockRHER2 aberrations in cancer: implications for therapyCancer Treat Rev201440677078024656976
  • MolinaMASáezRRamseyEENH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancerClin Cancer Res20028234735311839648
  • TevaarwerkAJKolesarJMLapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancerClin Ther200931Pt 22332234820110044
  • MaruyamaSChengJShingakiSEstablishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary glandBMC Cancer2009924719622142
  • WolffACHammondMEHicksDGRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateArch Pathol Lab Med2014138224125624099077
  • ShihJBashirBGustafsonKSCancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung PrimaryJ Natl Compr Canc Netw201513894795226285240
  • UlasAKosTAvciNPatients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survivalAsian Pac J Cancer Prev20151641643164925743846
  • LongvaKEPedersenNMHaslekåsCStangEMadshusIHHerceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2Int J Cancer2005116335936715800944
  • SakaiKYokoteHMurakami-MurofushiKTamuraTSaijoNNishioKPertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathwayCancer Sci20079891498150317627612
  • ZhouXTanMStone HawthorneVActivation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancersClin Cancer Res200410206779678815501954
  • OhtsukaTSakaguchiMYamamotoHInteraction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathwaySci Rep201663955728008968
  • WoodERTruesdaleATMcDonaldOBA unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cellsCancer Res200464186652665915374980
  • NishimuraRTohUTanakaMRole of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to TrastuzumabOncology2017931516128478451
  • FalchookGSLippmanSMBastidaCCKurzrockRHuman epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatmentHead Neck2014363E25E2723852769
  • BurrisHADual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinibOncologist20049Suppl 31015
  • NishijimaTYamamotoHNakanoTDual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenomaHum Pathol201546111730174326345124

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.